跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,889 条关于
“Union Cabinet”
全部
1,889
临床试验
393
药物
52
机构
29
资讯
1,415
11个月前
India Approves ₹1,500 Crore Biomedical Research Career Programme Phase III to Train 2,000 Scientists by 2031
去年
India Updates Drug and Healthcare Regulations, August 2024
2年前
Cabometyx Demonstrates Significant Efficacy in Advanced Neuroendocrine Tumors
去年
Cabozantinib Significantly Improves Progression-Free Survival in Advanced Neuroendocrine Tumors
上个月
India's BioE3 Policy Drives Over 270 Biomanufacturing Projects and 15 Bio-AI Hubs Nationwide
去年
Cabozantinib Demonstrates Promising Results in Neuroendocrine Tumors, Analyst Recommends 'Buy' for Exelixis
去年
BridgeBio's Attruby Approved for ATTR-CM Amidst Other Biopharma Developments
去年
Cabozantinib Shows Promise in Advanced GI Neuroendocrine Tumors
2年前
Cabometyx Demonstrates Significant Efficacy in Advanced Neuroendocrine Tumors
2年前
Cabozantinib Shows Promise in Advanced Neuroendocrine Tumors in Phase III CABINET Trial
第 1 页,共 142 页
上一页
下一页